Morgan Stanley’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,714,813
Closed -$26.2M 8339
2025
Q4
$26.2M Sell
1,714,813
-94,609
-5% -$1.41M ﹤0.01% 2676
2025
Q3
$26.9M Sell
1,809,422
-22,813
-1% -$331K ﹤0.01% 2593
2025
Q2
$26.3M Sell
1,832,235
-58,331
-3% -$812K ﹤0.01% 2540
2025
Q1
$27.4M Buy
1,890,566
+7,197
+0.4% +$108K ﹤0.01% 2371
2024
Q4
$28.4M Buy
1,883,369
+248,939
+15% +$3.77M ﹤0.01% 2400
2024
Q3
$24.3M Buy
1,634,430
+234,062
+17% +$3.36M ﹤0.01% 2605
2024
Q2
$19.6M Buy
1,400,368
+26,974
+2% +$378K ﹤0.01% 2693
2024
Q1
$20.1M Sell
1,373,394
-844,488
-38% -$12.2M ﹤0.01% 2686
2023
Q4
$31.1M Buy
2,217,882
+1,133,208
+104% +$15.4M ﹤0.01% 2937
2023
Q3
$14.9M Buy
1,084,674
+152,833
+16% +$2.16M ﹤0.01% 2755
2023
Q2
$13.1M Sell
931,841
-56,327
-6% -$816K ﹤0.01% 2909
2023
Q1
$14.5M Sell
988,168
-135,196
-12% -$2.05M ﹤0.01% 2778
2022
Q4
$17.4M Buy
1,123,364
+167,903
+18% +$2.55M ﹤0.01% 2483
2022
Q3
$12.9M Buy
955,461
+66,698
+8% +$1.03M ﹤0.01% 2684
2022
Q2
$13.6M Buy
888,763
+210,619
+31% +$3.37M ﹤0.01% 2725
2022
Q1
$11.3M Sell
678,144
-24,379
-3% -$409K ﹤0.01% 2777
2021
Q4
$12.5M Sell
702,523
-175,296
-20% -$3.06M ﹤0.01% 2688
2021
Q3
$14.7M Sell
877,819
-40,588
-4% -$700K ﹤0.01% 2432
2021
Q2
$15.6M Sell
918,407
-1,261
-0.1% -$21.2K ﹤0.01% 2443
2021
Q1
$14.9M Buy
919,668
+116,643
+15% +$1.79M ﹤0.01% 2226
2020
Q4
$12.2M Buy
803,025
+83,877
+12% +$1.2M ﹤0.01% 2298
2020
Q3
$9.73M Buy
719,148
+92,831
+15% +$1.28M ﹤0.01% 2057
2020
Q2
$8.52M Sell
626,317
-28,472
-4% -$380K ﹤0.01% 2116
2020
Q1
$8.2M Sell
654,789
-58,819
-8% -$945K ﹤0.01% 1954
2019
Q4
$12.6M Buy
713,608
+5,520
+0.8% +$98.3K ﹤0.01% 2143
2019
Q3
$12.6M Sell
708,088
-24,496
-3% -$432K ﹤0.01% 1889
2019
Q2
$12.9M Buy
732,584
+28,957
+4% +$511K ﹤0.01% 1887
2019
Q1
$12.7M Buy
703,627
+15,750
+2% +$277K ﹤0.01% 1803
2018
Q4
$11.1M Buy
687,877
+87,084
+14% +$1.56M ﹤0.01% 2025
2018
Q3
$11.9M Buy
600,793
+83,628
+16% +$1.6M ﹤0.01% 2242
2018
Q2
$9.56M Buy
517,165
+53,922
+12% +$1.01M ﹤0.01% 2421
2018
Q1
$8.23M Buy
463,243
+65,333
+16% +$1.2M ﹤0.01% 2528
2017
Q4
$7.5M Buy
397,910
+50,528
+15% +$902K ﹤0.01% 2681
2017
Q3
$5.89M Buy
347,382
+72,853
+27% +$1.22M ﹤0.01% 2777
2017
Q2
$4.54M Buy
274,529
+27,465
+11% +$444K ﹤0.01% 2951
2017
Q1
$3.87M Buy
247,064
+39,097
+19% +$612K ﹤0.01% 3138
2016
Q4
$3.12M Buy
207,967
+13,859
+7% +$201K ﹤0.01% 3491
2016
Q3
$2.8M Buy
194,108
+5,577
+3% +$81.7K ﹤0.01% 3209
2016
Q2
$2.74M Sell
188,531
-8,249
-4% -$117K ﹤0.01% 3154
2016
Q1
$2.78M Sell
196,780
-50,538
-20% -$678K ﹤0.01% 3073
2015
Q4
$3.55M Sell
247,318
-34,443
-12% -$491K ﹤0.01% 2989
2015
Q3
$3.8M Sell
281,761
-9,290
-3% -$133K ﹤0.01% 2900
2015
Q2
$4.32M Sell
291,051
-4,483
-2% -$68.1K ﹤0.01% 2920
2015
Q1
$4.48M Buy
295,534
+15,644
+6% +$241K ﹤0.01% 2858
2014
Q4
$4.32M Buy
+279,890
New +$4.51M ﹤0.01% 2863

Other funds holding DIAX

Morgan Stanley's DIAX Position: Q1 2026 in Review

Morgan Stanley sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 1,714,813 shares — an estimated $26.2M sold.

Morgan Stanley first reported a position in DIAX in Q4 2014 and held it in 45 quarters. The position peaked at $31.1M in Q4 2023. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.

  • Morgan Stanley reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 1,714,813 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $26.2M.
  • Morgan Stanley first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2014 and held it in 45 quarters.
  • Morgan Stanley's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $31.1M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.